Breakthrough Treatment

Blog image 1

Breakthrough Treatment for Patients with Barrett’s Esophagus

Saint Francis now offers the Barrx radiofrequency ablation system, a treatment that removes esophageal tissues affected by Barrett’s esophagus, a pre-cancerous disease (dysplastic Barret’s Esophagus).

If you suffer from heartburn or other acid reflux symptoms, such as chronic heartburn or gastroesophageal reflux disease (GERD), you may be at risk for Barrett’s esophagus, a serious disease that can eventually lead to esophageal cancer. Barrett’s Esophagus occurs when cells in the lower esophagus are affected by chronic exposure to acid. Because of its strong association with esophageal cancer, it is considered a pre-cancerous disease. More than 12.5 million people in the US have Barrett’s Esophagus, many of whom are not even diagnosed.

Diagnosis of Barrett’s Esophagus requires patients to undergo an upper endoscopy, a non-surgical procedure. During endoscopy, the physician removes esophagus tissues for biopsy to confirm the diagnosis. Patients diagnosed the Barrett’s Esophagus may be candidates for outpatient Barrx radiofrequency ablation.

The Barrx radiofrequency ablation system is a very specific type of ablation, in which thermal (heat) energy is delivered in a precise and highly controlled manner. Barrett’s Esophagus tissue is very thin, and therefore, a good candidate for removal with ablative energy. Delivery of ablative energy with the Barrx radiofrequency ablation system can achieve complete removal of the underlying structures. Clinical studies have demonstrated that Barrett’s Esophagus tissue can be completely eliminated with the Barrx radiofrequency ablation system in more than 90 perfect of patients.

For more information on Barrx radiofrequency ablation system, please contact the following doctors performing this procedure at Saint Francis Hospital:
Shailendra Singh, MD
Jeremy Stapleton, DO
Hamza Shah, DO
Charleston Gastroenterology
3100 MacCorkle Avenue SE
Suite 509
Charleston, WV 25304